Malluche HH - Search Results

1

Sotatercept Safety and Effects on Hemoglobin, Bone, and Vascular Calcification.

Coyne DW, Singh HN, Smith WT, Giuseppi AC, Connarn JN, Sherman ML, Dellanna F, Malluche HH, Hruska KA. Coyne DW, et al. Among authors: malluche hh. Kidney Int Rep. 2019 Aug 13;4(11):1585-1597. doi: 10.1016/j.ekir.2019.08.001. eCollection 2019 Nov. Kidney Int Rep. 2019. PMID: 31891000 Free PMC article.

2

The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.

London G, Coyne D, Hruska K, Malluche HH, Martin KJ. London G, et al. Among authors: malluche hh. Clin Nephrol. 2010 Dec;74(6):423-32. Clin Nephrol. 2010. PMID: 21084045 Free PMC article.

3

Early chronic kidney disease-mineral bone disorder stimulates vascular calcification.

Fang Y, Ginsberg C, Sugatani T, Monier-Faugere MC, Malluche H, Hruska KA. Fang Y, et al. Kidney Int. 2014 Jan;85(1):142-50. doi: 10.1038/ki.2013.271. Epub 2013 Jul 24. Kidney Int. 2014. PMID: 23884339 Free PMC article.

4

Expression of DGCR8-dependent microRNAs is indispensable for osteoclastic development and bone-resorbing activity.

Sugatani T, Hildreth BE 3rd, Toribio RE, Malluche HH, Hruska KA. Sugatani T, et al. Among authors: malluche hh. J Cell Biochem. 2014 Jun;115(6):1043-7. doi: 10.1002/jcb.24759. J Cell Biochem. 2014. PMID: 24420069 Free PMC article.

5

CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorder.

Fang Y, Ginsberg C, Seifert M, Agapova O, Sugatani T, Register TC, Freedman BI, Monier-Faugere MC, Malluche H, Hruska KA. Fang Y, et al. J Am Soc Nephrol. 2014 Aug;25(8):1760-73. doi: 10.1681/ASN.2013080818. Epub 2014 Feb 27. J Am Soc Nephrol. 2014. PMID: 24578135 Free PMC article. Clinical Trial.

6

SIRT6 deficiency culminates in low-turnover osteopenia.

Sugatani T, Agapova O, Malluche HH, Hruska KA. Sugatani T, et al. Among authors: malluche hh. Bone. 2015 Dec;81:168-177. doi: 10.1016/j.bone.2015.07.018. Epub 2015 Jul 17. Bone. 2015. PMID: 26189760 Free PMC article.

7

Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.

Sugatani T, Agapova OA, Fang Y, Berman AG, Wallace JM, Malluche HH, Faugere MC, Smith W, Sung V, Hruska KA. Sugatani T, et al. Among authors: malluche hh. Kidney Int. 2017 Jan;91(1):86-95. doi: 10.1016/j.kint.2016.07.039. Epub 2016 Sep 22. Kidney Int. 2017. PMID: 27666759 Free PMC article.

8

The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.

Williams MJ, Sugatani T, Agapova OA, Fang Y, Gaut JP, Faugere MC, Malluche HH, Hruska KA. Williams MJ, et al. Among authors: malluche hh. Kidney Int. 2018 Jan;93(1):147-158. doi: 10.1016/j.kint.2017.06.016. Epub 2017 Aug 23. Kidney Int. 2018. PMID: 28843411 Free PMC article.

9

Importance of bone turnover for therapeutic decisions in patients with CKD-MBD.

Ott SM, Malluche HH, Jorgetti V, Elder GJ. Ott SM, et al. Among authors: malluche hh. Kidney Int. 2021 Sep;100(3):502-505. doi: 10.1016/j.kint.2021.05.024. Kidney Int. 2021. PMID: 34420656

10

Low Turnover Renal Osteodystrophy With Abnormal Bone Quality and Vascular Calcification in Patients With Mild-to-Moderate CKD.

El-Husseini A, Abdalbary M, Lima F, Issa M, Ahmed MT, Winkler M, Srour H, Davenport D, Wang G, Faugere MC, Malluche HH. El-Husseini A, et al. Among authors: malluche hh. Kidney Int Rep. 2022 Mar 6;7(5):1016-1026. doi: 10.1016/j.ekir.2022.02.022. eCollection 2022 May. Kidney Int Rep. 2022. PMID: 35570986 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page